Dynamics of microcyst-like epithelial changes associated with Belantamab mafodotin therapy in a patient with multiple myeloma-a case report

Blood Cancer J. 2024 Aug 7;14(1):133. doi: 10.1038/s41408-024-01110-x.
No abstract available

Publication types

  • Letter
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antineoplastic Agents / adverse effects
  • Humans
  • Indoles
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / pathology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • belantamab mafodotin
  • Indoles